Tardive Dyskinesia (TD)

Tardive Dyskinesia (TD) is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as: Tardive Dyskinesia
Classified under: Chemically-Induced Disorders
Mental Disorders
Nervous System Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Clonazepam
Deutetrabenazine
Tetrabenazine
Valbenazine

Resolves to

Vocabularies

MeSHM000612971ICD-10G24.01SNOMED CT102449007MedDRA10013928UMLSC0543891

What you can answer from here — as of October 25, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

45Clinical trialsPhase, status and sponsor resolved per trial

1Boxed warningLabel boxed warnings that name this condition

38Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Tardive Dyskinesia (TD) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.